Nerve graft prefabrication: preliminary study.

Area of Science:

• Regenerative Medicine
• Biotechnology
• Neurosurgery

Background:

• Autologous nerve grafts are the gold standard for nerve repair but cause donor site morbidity.
• Segmental nerve defects require effective reconstructive strategies to restore function.

Purpose of the Study:

• To develop a prefabricated nerve graft using autologous vein conduits combined with gene therapy.
• To evaluate the efficacy of this novel nerve graft in repairing segmental nerve defects in a rat model.
• To achieve nerve regeneration comparable to autologous grafts without donor site complications.

Main Methods:

• Utilized autologous vein grafts as conduits for bridging nerve gaps in rat tibial and peroneal nerves.
• Employed gene therapy by injecting plasmid containing vascular endothelial growth factor (VEGF) to enhance nerve regeneration.
• Assessed functional and morphological outcomes at 8 weeks post-implantation.

Main Results:

• The study compared three groups: vein graft alone, modified vein graft, and vein graft with VEGF gene therapy.
• Preliminary results suggest the combination of vein conduit and VEGF gene therapy promotes nerve regeneration.
• Functional and morphological assessments indicated potential for this approach in nerve defect repair.

Conclusions:

• Prefabricated nerve grafts using autologous veins and VEGF gene therapy offer a promising alternative for segmental nerve defect repair.
• This approach may mitigate donor site morbidity associated with traditional autologous nerve grafting.
• Further research is warranted to optimize the technique and confirm long-term efficacy.